Eximo Medical has recently launched its B-Laser Atherectomy System for patients who have arterial occlusive peripheral arterial disease.
The system was launched in a step-by-step approach for therapy in patients who have highly complex, arterial occlusive peripheral arterial disease. The step-by-step crossing approach uses a standard B-Laser catheter followed by the atherectomy using the same catheter that is used with standard guidewires.
During a Polish study, the B-Laser system was successful without complications, including in long and severely calcified lesions. Eximo’s On-Line Photo-Acoustic Signal Monitoring was also implemented for the first time during the study and showed that machine learning can help interventionists characterize materials that are in contact with catheter tips while also providing a warning signal to prevent vessel injury and procedural complications.
“There is a well-known paucity of devices that allows interventionists to cross occlusive lesions in an intraluminal path as opposed to sub-intimal. I am very excited to work with Eximo using the B-Laser in a variety of PAD patients and to incorporate it routinely in our outpatient-based laboratory,” said Dr. Luis Leon, a clinician that has begun using the B-Laser system to treat patients, in a press release. “The capability to cross chronically occluded arteries without needing to cross with a wire first, and to then be able to perform atherectomy over a wire by using the same catheter represents a welcomed and significant addition to our toolkit as it addresses a real unmet need in our practice. I am very proud to be part of this exciting technology and journey.”
The B-Laser has so far been used to treat patients who have highly complex, highly calcified lesions above and below the arterial segments in the knee.
“Eximo is extremely excited with the current commercial progress the B-Laser is experiencing in the competitive U.S. market. We continue to leverage the inherent advantages of our unique short pulse 355nm laser platform to develop novel techniques and expand our system’s utilization and market opportunity. It was a significant milestone for us to show B-Laser’s ability to cross a highly calcified lesion using the step-by-step technique without the need to cross with a wire first in very challenging scenarios (including long and severely calcific lesions),” said Yoel Zabar, CEO of Eximo Medical. “I am also excited to see our Photo-Acoustic Monitoring technology successfully employed in clinical cases; we believe this technology in time has the potential to shift therapeutic practice,”
